Wakefield Asset Management’s Pediatrix Medical MD Stock Holding History

Wakefield Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	54,597 +1,068	+2%	+$24.3K	0.31%	98
2026 Q1	$1.14M	Buy	53,529 +334	+0.6%	+$6.95K	0.3%	106
2025 Q4	$1.14M	Sell	53,195 -16,710	-24%	-$342K	0.31%	99
2025 Q3	$1.17M	Buy	69,905 +114	+0.2%	+$1.71K	0.32%	100
2025 Q2	$1M	Buy	+69,791	New	+$957K	0.28%	121
2022 Q3	–	Sell	-35,523	Closed	-$746K	–	188
2022 Q2	$746K	Sell	35,523 -34	-0.1%	-$694	0.32%	82
2022 Q1	$835K	Buy	+35,557	New	+$870K	0.3%	100

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wakefield Asset Management's MD Position: Q2 2026 in Review

Wakefield Asset Management increased its Pediatrix Medical (MD) stake by 2% in Q2 2026, buying an estimated $24.3K and bringing the position to 54,597 shares worth $1.38M. The position accounts for 0.31% of the portfolio, ranked #98.

Wakefield Asset Management first reported a position in MD in Q1 2022 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Wakefield Asset Management held 54,597 shares of Pediatrix Medical worth $1.38M as of Q2 2026.
Wakefield Asset Management bought 1,068 Pediatrix Medical shares in Q2 2026, an estimated $24.3K.
Pediatrix Medical made up 0.31% of Wakefield Asset Management's portfolio in Q2 2026, its #98 holding.
Wakefield Asset Management first reported a position in Pediatrix Medical in Q1 2022 and has held it in 7 quarters since.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.